KODIAK SCIENCES INC. Operating Lease Liability
KODIAK SCIENCES INC. (KOD) had Operating Lease Liability of $59.18 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-31
- 2025-12-31: Operating Lease, Liability $59.18M.
- 2024-12-31: Operating Lease, Liability $70.34M.
- 2023-12-31: Operating Lease, Liability $81.63M.
- 2023-09-30: Operating Lease, Liability $26.80M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $59.18M 10-K · filed 2026-03-31 |
| 2024-12-31 | $70.34M 10-K · filed 2025-03-27 |
| 2023-12-31 | $81.63M 10-K · filed 2024-03-28 |
| 2023-09-30 | $26.80M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $6.80M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $87.73M 10-K · filed 2023-03-28 |
| 2021-12-31 | $80.00M 10-K · filed 2022-03-01 |
| 2020-12-31 | $77.40M 10-K · filed 2021-03-01 |
| 2020-09-30 | $77.32M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.73M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $1.94M 10-K · filed 2020-03-16 |
| 2019-09-30 | $2.04M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.13M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.27M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |